This inventor holds 1 USPTO granted patent. Top assignee: Columbia University. Active years: 2013.
Company Filing History:
Years Active: 2013
Introduction
Irina Potapova, a prominent researcher based in Stony Brook, NY, is making significant strides in the field of cardiac health. With a focus on stem cell differentiation and repair mechanisms, she has dedicated her career to innovating methods that could potentially transform treatments for patients suffering from cardiac disorders.
Latest Patents
Irina Potapova holds a notable patent titled "Differentiation of human mesenchymal stem cells to cardiac progenitor cells that promote cardiac repair." This innovative method provides a therapeutic approach for treating subjects with cardiac disorders by inducing differentiation of progenitor cells in vitro into cardiogenic cells, and subsequently administering these cells to the patient. The intricacies of her invention extend to related articles of manufacture and methods, demonstrating her comprehensive understanding of the field.
Career Highlights
Throughout her career, Irina has contributed significantly to research and innovation in cardiac repair strategies. Her affiliation with Columbia University has positioned her at the forefront of transformative biomedical research, allowing her to develop cutting-edge methodologies that aim to improve patient outcomes.
Collaborations
Irina works alongside esteemed colleagues Richard B. Robinson and Michael R. Rosen, who have each played an integral role in furthering the research initiatives at Columbia University. This collaborative environment fosters innovative thinking and accelerates the translation of research findings into clinically relevant applications.
Conclusion
Irina Potapova exemplifies the impact of innovation in the medical field, particularly in cardiac care through stem cell research. Her patent underscores the potential for advancements in therapeutic strategies, paving the way for enhanced treatments for those afflicted with cardiac disorders. As she continues her work at Columbia University, the future of cardiac repair looks promising with her contributions and dedication.